Skye Bioscience (SKYE) Institutional Ownership $3.48 +0.02 (+0.58%) Closing price 04:00 PM EasternExtended Trading$3.51 +0.03 (+0.75%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Skye Bioscience (NASDAQ:SKYE)CurrentInstitutional OwnershipPercentage21.09%Number ofInstitutional Buyers(last 12 months)27TotalInstitutional Inflows(last 12 months)$19.71MNumber ofInstitutional Sellers(last 12 months)13TotalInstitutional Outflows(last 12 months)$6.12M Get SKYE Insider Trade Alerts Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data SKYE Institutional Buying and Selling by Quarter Skye Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 10,927$46K0.0%+121.3%0.035% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.289,979$1.21M0.0%-6.5%0.936% 8/14/2025 Qube Research & Technologies Ltd52,204$218K0.0%N/A0.168% 8/13/2025 Capital Advisors Wealth Management LLC50,800$212K0.0%+143.1%0.164% 8/13/2025 Marshall Wace LLP104,347$436K0.0%N/A0.337% 8/13/2025 Millington Financial Advisors LLC10,000$44K0.0%N/A0.032% 8/8/2025 Geode Capital Management LLC201,921$844K0.0%-54.2%0.652% 8/1/2025 Y Intercept Hong Kong Ltd10,046$42K0.0%N/A0.032% 6/27/2025 Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140% 5/16/2025 Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140% Get the Latest News and Ratings for SKYE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.310,013$493K0.0%-5.0%1.001% 5/15/2025 Driehaus Capital Management LLC620,395$986K0.0%-4.7%2.003% 5/13/2025 Altium Capital Management LLC904,865$1.44M3.5%-20.6%2.921% 5/12/2025 Nuveen LLC23,389$37K0.0%N/A0.076% 4/25/2025 Capital Advisors Wealth Management LLC20,900$33K0.0%N/A0.067% 2/17/2025 Squarepoint Ops LLC13,546$38K0.0%N/A0.045% 2/17/2025 Two Sigma Advisers LP11,200$32K0.0%N/A0.037% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.326,241$923K0.0%-5.3%1.075% 2/17/2025 Ensign Peak Advisors Inc767,287$2.17M0.0%-14.7%2.529% 2/17/2025 Deutsche Bank AG40,835$116K0.0%+365.0%0.135% 2/17/2025 Bridgeway Capital Management LLC72,000$204K0.0%+26.3%0.237% 2/17/2025 Braidwell LP825,732$2.34M0.1%N/A2.722% 2/17/2025 Baker BROS. Advisors LP1,450,638$4.11M0.0%+1.1%4.781% 2/17/2025 Bank of America Corp DE39,257$111K0.0%+37.4%0.129% 2/17/2025 BNP Paribas Financial Markets31,637$90K0.0%-33.3%0.104% 2/17/2025 Alyeska Investment Group L.P.456,163$1.29M0.0%-17.7%1.504% 2/14/2025 Jane Street Group LLC36,057$102K0.0%+195.5%0.119% 2/14/2025 Schonfeld Strategic Advisors LLC1,422,741$4.03M0.0%+48.3%4.689% 2/14/2025 AdvisorShares Investments LLC88,391$250K0.0%-23.1%0.291% 2/14/2025 Northern Trust Corp135,712$384K0.0%-3.7%0.447% 2/14/2025 Altium Capital Management LLC1,139,000$3.22M0.9%-13.4%3.754% 2/13/2025 Barclays PLC69,620$198K0.0%+20.3%0.229% 2/13/2025 Wells Fargo & Company MN11,199$32K0.0%+49.0%0.037% 2/12/2025 Geode Capital Management LLC405,694$1.15M0.0%+5.2%1.337% 2/11/2025 Virtu Financial LLC10,142$29K0.0%N/A0.033% 2/11/2025 Platinum Investment Management Ltd.434,046$1.23M0.1%-10.5%1.431% 2/6/2025 Charles Schwab Investment Management Inc.62,363$176K0.0%+20.7%0.206% 1/1/2025 JPMorgan Chase & Co.11,362$44K0.0%-24.1%0.037% 11/19/2024 Barclays PLC57,889$226K0.0%+36.7%0.191% 11/16/2024 Geode Capital Management LLC385,793$1.51M0.0%+4.2%1.272% NVIDIA's Worst Nightmare? (Ad)$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the REAL fortune they expect to come from quantum computing - a $2 trillion explosion by 2035. The kicker? One company is America's FIRST commercial supplier of the material that makes it possible.Click here to learn how to get the ticker symbol <<<11/15/2024 Barclays PLC57,889$226K0.0%+36.7%0.191% 11/15/2024 Jane Street Group LLC12,200$48K0.0%N/A0.040% 11/15/2024 Sphera Funds Management LTD.1,563,522$6.11M1.0%+20.4%5.153% 11/15/2024 State Street Corp354,205$1.39M0.0%+7.0%1.167% 11/15/2024 Point72 Asset Management L.P.416,424$1.63M0.0%-25.6%1.373% 11/15/2024 Baker BROS. Advisors LP1,434,634$5.61M0.1%+186.9%4.729% 11/13/2024 BNP Paribas Financial Markets47,417$185K0.0%+71.1%0.156% 9/16/2024 Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 9/16/2024 Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 9/16/2024 Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% 8/19/2024 Point72 Asset Management L.P.560,000$4.49M0.0%N/A1.995% 8/16/2024 Perceptive Advisors LLC500,000$4.01M0.1%N/A1.781% 8/16/2024 Driehaus Capital Management LLC650,758$5.21M0.0%N/A2.319% 8/15/2024CVI Holdings LLC679,739$5.45M4.9%N/A2.422% 8/15/2024 Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% 8/14/2024 Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 8/14/2024 Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 8/14/2024 Logos Global Management LP1,301,518$10.43M0.8%N/A4.637% 8/8/2024 AdvisorShares Investments LLC26,000$210K0.0%N/A0.093% 8/1/2024 Rhumbline Advisers19,754$158K0.0%N/A0.070% 7/26/2024 Bank of New York Mellon Corp58,778$471K0.0%N/A0.209% (Data available from 1/1/2016 forward) SKYE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SKYE shares? During the previous two years, 43 institutional investors and hedge funds held shares of Skye Bioscience. The most heavily invested institutionals were Logos Global Management LP ($10.43M), Sphera Funds Management LTD. ($6.11M), CVI Holdings LLC ($5.45M), Baker BROS. Advisors LP ($4.11M), Schonfeld Strategic Advisors LLC ($4.03M), Perceptive Advisors LLC ($4.01M), and Braidwell LP ($2.34M).Learn more on Skye Bioscience's institutional investors. What percentage of Skye Bioscience's stock is owned by institutional investors? 21.09% of Skye Bioscience's stock is owned by institutional investors. Learn more on SKYE's institutional investor holdings. Which institutional investors have been buying Skye Bioscience's stock? Of the 35 institutional investors that purchased Skye Bioscience's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Logos Global Management LP ($1.30M), Baker BROS. Advisors LP ($950.64K), Braidwell LP ($825.73K), CVI Holdings LLC ($679.74K), Driehaus Capital Management LLC ($650.76K), Point72 Asset Management L.P. ($560K), and Perceptive Advisors LLC ($500K). How much institutional buying is happening at Skye Bioscience? Institutional investors have bought a total of 3,063,868 shares in the last 24 months. This purchase volume represents approximately $19.71M in transactions. Which of Skye Bioscience's major shareholders have been selling company stock? Of the 13 institutional investors that sold Skye Bioscience's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Altium Capital Management LLC ($410.28K), Geode Capital Management LLC ($238.87K), Point72 Asset Management L.P. ($143.58K), Ensign Peak Advisors Inc ($132.71K), Alyeska Investment Group L.P. ($98.01K), Goldman Sachs Group Inc. ($55.18K), and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($54.48K). How much institutional selling is happening at Skye Bioscience? Institutional investors have sold a total of 1,265,792 shares in the last 24 months. This volume of shares sold represents approximately $6.12M in transactions. Related Companies REPL Major Shareholders ESPR Major Shareholders CYRX Major Shareholders IVA Major Shareholders CMPX Major Shareholders AUTL Major Shareholders IMAB Major Shareholders CRVS Major Shareholders KMDA Major Shareholders AURA Major Shareholders This page (NASDAQ:SKYE) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access